1. Home
  2. Directory
  3. Michigan
  4. Columbus
  5. Dermatology
  6. NPI Profile

DR. JOHN MICHAEL PELACHYK M.D.
NPI 1528052834
Dermatology - Dermatopathology in Columbus, MI

Active since September 01, 2005
9280 BARTEL RD, COLUMBUS, MI 48063(586) 727-3643 Get Directions Write a Review

NPPES record last updated: April 25, 2022. Verified against the NPPES registry weekly; last sync: August 09, 2026.

Record update history: Apr 25, 2022, Sep 21, 2021, Feb 23, 2021 and 1 more (4 updates tracked since 2019).

About Dr. John Michael Pelachyk M.d. NPPES

Official registry information on file with the National Plan and Provider Enumeration System.

DR. JOHN MICHAEL PELACHYK M.D. (NPI 1528052834) is an individual dermatopathology provider in Columbus, Michigan, licensed in Michigan (4301042820) and active in the NPI registry since September 2005.

NPPES Registry Identity

NPI1528052834
Entity TypeIndividualMale
Primary Taxonomy207ND0900X
Provider Legal NameDR. JOHN MICHAEL PELACHYKCredential: M.D.
Location Address9280 BARTEL RDColumbus, MI 48063-4204
Mailing Address9280 Bartel RdColumbus, MI 48063-4204 · (586) 727-3643
Phone(586) 727-3643
Sole ProprietorNo
Enumeration DateSeptember 1, 2005
Last NPPES UpdateApril 25, 20224 updates tracked since enumeration
NPPES CertifiedApril 25, 2022
✔ NPI 1528052834 is a valid, active identifier and passes the ISO check-digit test.

Specialties & Licenses

★ Primary SpecialtyDermatology · DermatopathologyAllopathic & Osteopathic Physicians
Taxonomy Code207ND0900X
License✔ Licensed in MI · 4301042820
Definition
A dermatopathologist has the expertise to diagnose and monitor diseases of the skin including infectious, immunologic, degenerative and neoplastic diseases. This entails the examination and interpretation of specially prepared tissue sections, cellular scrapings and smears of skin lesions by means of routine and special (electron and fluorescent) microscopes.
9280 BARTEL RD, Columbus, MI 48063
Open in Google Maps ↗

Accepted Insurance

The full list of accepted plans is on the Insurance tab. Issuers include McLaren Health Plan Community.Insurance ›

Medicare Quality Performance CMS QPP · MIPS

Performance in the CMS Quality Payment Program: the MIPS final score across four weighted categories, and the individual quality measures reported to Medicare.

Reported Quality Measures

Biopsy Follow-Up
Percentage of new patients whose biopsy results have been reviewed and communicated to the primary care/referring physician and patient by the performing physician
83%35 patients4/55-star benchmark: 100%
Documentation of Current Medications in the Medical Record
Percentage of visits for patients aged 18 years and older for which the eligible professional or eligible clinician attests to documenting a list of current medications using all immediate resources available on the date of the encounter.
100%2,520 patients5/55-star benchmark: 100%
e-Prescribing
At least one permissible prescription written by the MIPS eligible clinician is queried for a drug formulary and transmitted electronically using certified EHR technology.
89%1,864 patients4/55-star benchmark: 100%
Health Information Exchange
The MIPS eligible clinician that transitions or refers their patient to another setting of care or health care clinician (1) uses CEHRT to create a summary of care record; and (2) electronically transmits such summary to a receiving health care clinician for…
72%94 patients3/55-star benchmark: 98%
Medication Reconciliation
The MIPS eligible clinician performs medication reconciliation for at least one transition of care in which the patient is transitioned into the care of the MIPS eligible clinician.
100%478 patients5/55-star benchmark: 100%
Patient-Specific Education
The MIPS eligible clinician must use clinically relevant information from CEHRT to identify patient-specific educational resources and provide access to those materials to at least one unique patient seen by the MIPS eligible clinician.
14%2,140 patients1/55-star benchmark: 100%
Pneumococcal Vaccination Status for Older Adults
Percentage of patients 65 years of age and older who have ever received a pneumococcal vaccine
1%1,238 patients1/55-star benchmark: 90%
Preventive Care and Screening: Influenza Immunization
Percentage of patients aged 6 months and older seen for a visit between October 1 and March 31 who received an influenza immunization OR who reported previous receipt of an influenza immunization
3%1,179 patients1/55-star benchmark: 88%
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
Percentage of patients aged 18 years and older who were screened for tobacco use one or more times within 24 months AND who received tobacco cessation intervention if identified as a tobacco user
Patients screenedForUse: 100% · 569 patients
Patients tobacco: 100% · 569 patients
100%41 patients5/55-star benchmark: 98%
Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling
Percentage of patients aged 18 years and older who were screened for unhealthy alcohol use using a systematic screening method at least once within the last 24 months AND who received brief counseling if identified as an unhealthy alcohol user
38%569 patients2/55-star benchmark: 100%
Provide Patient Access
At least one patient seen by the MIPS eligible clinician during the performance period is provided timely access to view online, download, and transmit to a third party their health information subject to the MIPS eligible clinician's discretion to withhold…
99%2,140 patients4/55-star benchmark: 100%
Psoriasis: Clinical Response to Oral Systemic or Biologic Medications
Percentage of psoriasis vulgaris patients receiving oral systemic or biologic therapy who meet minimal physician-or patient- reported disease activity levels.
23%30 patients
Secure Messaging
For at least one unique patient seen by the MIPS eligible clinician during the performance period, a secure message was sent using the electronic messaging function of CEHRT to the patient (or the patient-authorized representative), or in response to a secure…
0%2,140 patients1/55-star benchmark: 79%
Tobacco Use and Help with Quitting Among Adolescents
The percentage of adolescents 12 to 20 years of age with a primary care visit during the measurement year for whom tobacco use status was documented and received help with quitting if identified as a tobacco user
97%60 patients
Providers report different measures because they deliver different services; reporting more or less information is not a reflection of quality. Star ratings appear only where CMS assigned them.

Frequently Asked Questions NPPES & CMS

Common questions about this NPI record, answered from the official NPPES registry and CMS datasets shown on this page.

What is John Pelachyk's NPI number?

The NPI number for John Pelachyk is 1528052834. It was assigned to this individual provider in the NPPES registry on September 1, 2005.

Where is John Pelachyk located?

John Pelachyk practices at 9280 Bartel Rd, Columbus, MI 48063. The listed phone number is (586) 727-3643.

What is John Pelachyk's specialty?

The primary specialty registered for this NPI is Dermatology, specializing in Dermatopathology, with taxonomy code 207ND0900X.

What insurance does John Pelachyk accept?

Health plans from McLaren Health Plan Community list John Pelachyk as in-network in at least one marketplace plan. Coverage varies by plan and year; verify with the insurer or the provider before a visit.

When was this NPI record last updated?

The NPPES record for John Pelachyk was last updated on April 25, 2022. NPI Profile syncs weekly with the NPPES registry data releases published by CMS. This NPI record was last updated 4 years ago. If this record has changed at CMS more recently, you can request an on-demand re-check against the live CMS registry, directly from this page.